129 related articles for article (PubMed ID: 10998026)
1. Preventive treatment of intranasal fluticasone propionate reduces cytokine mRNA expressing cells before and during a single nasal allergen provocation.
Kleinjan A; Holm AF; Dijkstra MD; Boks SS; Severijnen L; Mulder PG; Fokkens WJ
Clin Exp Allergy; 2000 Oct; 30(10):1476-85. PubMed ID: 10998026
[TBL] [Abstract][Full Text] [Related]
2. Nasal eosinophilia and IL-5 mRNA expression in seasonal allergic rhinitis induced by natural allergen exposure: effect of topical corticosteroids.
Masuyama K; Till SJ; Jacobson MR; Kamil A; Cameron L; Juliusson S; Lowhagen O; Kay AB; Hamid QA; Durham SR
J Allergy Clin Immunol; 1998 Oct; 102(4 Pt 1):610-7. PubMed ID: 9802369
[TBL] [Abstract][Full Text] [Related]
3. Topical glucocorticosteroid (fluticasone propionate) inhibits cells expressing cytokine mRNA for interleukin-4 in the nasal mucosa in allergen-induced rhinitis.
Masuyama K; Jacobson MR; Rak S; Meng Q; Sudderick RM; Kay AB; Lowhagen O; Hamid Q; Durham SR
Immunology; 1994 Jun; 82(2):192-9. PubMed ID: 7927488
[TBL] [Abstract][Full Text] [Related]
4. Fluticasone propionate aqueous nasal spray reduces inflammatory cells in unchallenged allergic nasal mucosa: effects of single allergen challenge.
Holm A; Dijkstra M; Kleinjan A; Severijnen LA; Boks S; Mulder P; Fokkens W
J Allergy Clin Immunol; 2001 Apr; 107(4):627-33. PubMed ID: 11295650
[TBL] [Abstract][Full Text] [Related]
5. Increase in IL-8, IL-10, IL-13, and RANTES mRNA levels (in situ hybridization) in the nasal mucosa after nasal allergen provocation.
KleinJan A; Dijkstra MD; Boks SS; Severijnen LA; Mulder PG; Fokkens WJ
J Allergy Clin Immunol; 1999 Mar; 103(3 Pt 1):441-50. PubMed ID: 10069878
[TBL] [Abstract][Full Text] [Related]
6. Intranasal fluticasone propionate inhibits recovery of chemokines and other cytokines in nasal secretions in allergen-induced rhinitis.
Weido AJ; Reece LM; Alam R; Cook CK; Sim TC
Ann Allergy Asthma Immunol; 1996 Nov; 77(5):407-15. PubMed ID: 8933780
[TBL] [Abstract][Full Text] [Related]
7. Once daily intranasal fluticasone propionate (200 micrograms) reduces nasal symptoms and inflammation but also attenuates the increase in bronchial responsiveness during the pollen season in allergic rhinitis.
Foresi A; Pelucchi A; Gherson G; Mastropasqua B; Chiapparino A; Testi R
J Allergy Clin Immunol; 1996 Aug; 98(2):274-82. PubMed ID: 8757203
[TBL] [Abstract][Full Text] [Related]
8. IL-13 mRNA and immunoreactivity in allergen-induced rhinitis: comparison with IL-4 expression and modulation by topical glucocorticoid therapy.
Ghaffar O; Laberge S; Jacobson MR; Lowhagen O; Rak S; Durham SR; Hamid Q
Am J Respir Cell Mol Biol; 1997 Jul; 17(1):17-24. PubMed ID: 9224205
[TBL] [Abstract][Full Text] [Related]
9. Influence of prolonged treatment with topical corticosteroid (fluticasone propionate) on early and late phase nasal responses and cellular infiltration in the nasal mucosa after allergen challenge.
Rak S; Jacobson MR; Sudderick RM; Masuyama K; Juliusson S; Kay AB; Hamid Q; Löwhagen O; Durham SR
Clin Exp Allergy; 1994 Oct; 24(10):930-9. PubMed ID: 7842362
[TBL] [Abstract][Full Text] [Related]
10. Expression of IL-4, Cepsilon RNA, and Iepsilon RNA in the nasal mucosa of patients with seasonal rhinitis: effect of topical corticosteroids.
Cameron LA; Durham SR; Jacobson MR; Masuyama K; Juliusson S; Gould HJ; Lowhagen O; Minshall EM; Hamid QA
J Allergy Clin Immunol; 1998 Mar; 101(3):330-6. PubMed ID: 9525448
[TBL] [Abstract][Full Text] [Related]
11. Prevention of pollen rhinitis symptoms: comparison of fluticasone propionate aqueous nasal spray and disodium cromoglycate aqueous nasal spray. A multicenter, double-blind, double-dummy, parallel-group study.
Bousquet J; Chanal I; Alquié MC; Charpin D; Didier A; Germouty J; Greillier P; Ickovic MH; Maria Y; Montané F
Allergy; 1993 Jul; 48(5):327-33. PubMed ID: 8368459
[TBL] [Abstract][Full Text] [Related]
12. Cytokine immunoreactivity in seasonal rhinitis: regulation by a topical corticosteroid.
Bradding P; Feather IH; Wilson S; Holgate ST; Howarth PH
Am J Respir Crit Care Med; 1995 Jun; 151(6):1900-6. PubMed ID: 7767538
[TBL] [Abstract][Full Text] [Related]
13. A double-blind comparison of fluticasone propionate aqueous nasal spray, terfenadine tablets and placebo in the treatment of patients with seasonal allergic rhinitis to grass pollen.
Darnell R; Pecoud A; Richards DH
Clin Exp Allergy; 1994 Dec; 24(12):1144-50. PubMed ID: 7889428
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and onset of action of fluticasone propionate aqueous nasal spray on nasal symptoms, eosinophil count, and mediator release after nasal allergen challenge in patients with seasonal allergic rhinitis.
Wang D; Duyck F; Smitz J; Clement P
Allergy; 1998 Apr; 53(4):375-82. PubMed ID: 9574879
[TBL] [Abstract][Full Text] [Related]
15. Granulocyte/macrophage-colony stimulating factor in allergen-induced rhinitis: cellular localization, relation to tissue eosinophilia and influence of topical corticosteroid.
Nouri-Aria KT; Masuyama K; Jacobson MR; Rak S; Lowhagen O; Schotman E; Hamid Q; Durham S
Int Arch Allergy Immunol; 1998 Dec; 117(4):248-54. PubMed ID: 9876226
[TBL] [Abstract][Full Text] [Related]
16. Comparison of a nasal glucocorticoid, antileukotriene, and a combination of antileukotriene and antihistamine in the treatment of seasonal allergic rhinitis.
Pullerits T; Praks L; Ristioja V; Lötvall J
J Allergy Clin Immunol; 2002 Jun; 109(6):949-55. PubMed ID: 12063523
[TBL] [Abstract][Full Text] [Related]
17. Grass pollen immunotherapy inhibits allergen-induced infiltration of CD4+ T lymphocytes and eosinophils in the nasal mucosa and increases the number of cells expressing messenger RNA for interferon-gamma.
Durham SR; Ying S; Varney VA; Jacobson MR; Sudderick RM; Mackay IS; Kay AB; Hamid QA
J Allergy Clin Immunol; 1996 Jun; 97(6):1356-65. PubMed ID: 8648033
[TBL] [Abstract][Full Text] [Related]
18. Topical corticosteroid inhibits interleukin-4, -5 and -13 in nasal secretions following allergen challenge.
Erin EM; Zacharasiewicz AS; Nicholson GC; Tan AJ; Higgins LA; Williams TJ; Murdoch RD; Durham SR; Barnes PJ; Hansel TT
Clin Exp Allergy; 2005 Dec; 35(12):1608-14. PubMed ID: 16393327
[TBL] [Abstract][Full Text] [Related]
19. Effect of intranasal fluticasone proprionate on the immediate and late allergic reaction and nasal hyperreactivity in patients with a house dust mite allergy.
de Graaf-in't Veld C; Garrelds IM; Jansen AP; Van Toorenenbergen AW; Mulder PG; Meeuwis J; Gerth van Wijk R
Clin Exp Allergy; 1995 Oct; 25(10):966-73. PubMed ID: 8556568
[TBL] [Abstract][Full Text] [Related]
20. Effect of topical fluticasone propionate on the mucosal allergic response induced by ragweed allergen and diesel exhaust particle challenge.
Diaz-Sanchez D; Tsien A; Fleming J; Saxon A
Clin Immunol; 1999 Mar; 90(3):313-22. PubMed ID: 10075860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
